On Sunday, Barry Block, DPM, JD, was awarded APMA’s highest honor, the Distinguished Service Citation. This award is given in recognition of outstanding sustained accomplishments on the national level in scientific, professional, or civic endeavors.
Read More
The 2025 APMA House of Delegates convened in Washington, DC, on Saturday morning. The house is the governing and legislative body of the organization with representatives from each of APMA’s 53 component associations.
Read More
In her first state of the association address to the House of Delegates, APMA CEO and Executive Director Meghan McClelland, MBA, outlined her vision for the association and moving podiatry into the future.
Read More
Brooke Bisbee, DPM, was installed as the 99th APMA president by Past President Lloyd Smith, DPM, during the opening day of the 2025 APMA House of Delegates. In her inaugural address, Dr. Bisbee shared her deep pride in her home state of Arkansas, known as the Natural State, and likened podiatry today to the process through which gems are formed.
Read More
APMA submitted comments to the Department of Health and Human Services (HHS) and the Office of Civil Rights (OCR), expressing significant concerns about the proposed changes to existing Health Insurance Portability and Accountability Act (HIPAA) on Thursday, March 6.
Read More
APMA, AMA, and 90 other health-care societies signed on to a letter, urging Congress to pass the “Medicare Patient Access and Practice Stabilization Act” (H.R. 879). This legislation would cancel the 2.83-percent cut to Medicare physician payment and provide a 2-percent payment increase, stabilizing practices and ensuring Medicare patients can continue to receive care.
Read More
Learn more about Talar Medical, APMA's preferred group purchasing organization.
Read More
All seven Part B Medicare Contractors have finalized local coverage determinations (LCDs) that will govern the provision of skin substitute grafts/cellular and tissue-based products to Medicare Part B beneficiaries when used for the treatment of diabetic foot ulcers and venous leg ulcers. As of March 4, these policies are still scheduled to take effect April 13, 2025.
Read More
Recently APMA provided feedback to the Partnership for Quality Measurement (PQM) Pre-Rulemaking Measure Review Committee (PRMR) regarding its posted 2024–25 Measures Under Consideration (MUC) List Recommendations. As APMA has continued and significant concerns with the Non-Pressure Ulcers Cost Measure, we urged CMS to not finalize this measure.
Read More
The code descriptors for commonly used DME-related HCPCS codes L:1932, L1933, L1951, and L1952 will change effective April 1. These positive changes eliminate the need to use HCPCS L2999 (Lower extremity orthoses, not otherwise specified) when these items are dispensed "off-the-shelf.”
Read More
On Monday, APMA submitted comments to CMS on the Advance Notice of Methodological Changes for Calendar Year (CY) 2026 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies.
Read More
